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Objective: Studies have indicated that AMPK play critical roles in the regulation of innate
immunity and inﬂammatory responses. However, the role of the polymorphisms of PRKAA1
gene  in immune-response to infectious organisms remains unknown. To evaluate the poten-
tial  role of PRKAA1/AMPK1 in the immune-response to HBV, we conducted this case–control
study.
Methods: We  recruited 276 patients (145 men and 131 women; average age, 51.6 years) with
chronic HBV infection (CHB) and 303 healthy controls (166 men and 137 women; average
age, 54.2 years). All the subjects were unrelated individuals of Chinese Han Population.
Three SNPs of PRKAA1gene were tested.
Results: Rs1002424 polymorphism showed signiﬁcant difference in the allele frequencies,
but  no difference in the genotype frequencies (allele: p = 0.039411, OR95%CI = 0.783479
[0.621067–0.988362]; genotype: p = 0.104758); rs13361707 polymorphism showed signiﬁcance
in  allele analysis, but not in genotype analysis (allele: p = 0.034749, OR95%CI = 1.284303
[1.017958–1.620335]; genotype: p = 0.098027); rs3792822 polymorphism was demonstrated to
have  signiﬁcant differences in both genotype and allele frequencies between cases and con-
trols (allele: p = 0.029286, OR95%CI= 0.741519 [0.566439–0.970716]; genotype: p = 0.034560).
The haplotype results showed that CTG and TCA in the rs13361707–rs1002424–rs3792822
block were signiﬁcantly associated with the happening of HBV (CTG: p = 0.036854,
OR95%CI = 1.281 [1.015–1.617]; p = 0.030841, OR95%CI = 0.743 [0.568–0.973]).
Conclusion: These ﬁndings suggest that PRKAA1 polymorphisms may contribute to the sus-ceptibility of chronic HBV infection in Chinese Han origin.
©  2016 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).∗ Corresponding author.
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ntroduction
denosine-monophosphate-activated protein kinase (AMPK)
s highly conserved hetero-trimeric serine/threonine protein
inase consists of a catalytic subunit (1 or 2) and two
egulatory  (1–2) and  subunits (1–3).1,2 It is ubiqui-
ously expressed and served as a master sensor of cellular
nergy homeostasis at the cellular and even whole-body
evel. AMPK is activated by the increase of AMP/ATP ratio
rom environmental or nutritional stress factors including oxi-
ants, hypoxia and nutrient deprivation,3,4 then the activated
inase phosphorylates and regulates a variety of down-
tream molecules that maintains the balance between the
onsumption and generation of cellular energy.5,6 Disrup-
ion of this balance results a number of diseases such as
iabetes, obesity, cardiovascular dysfunction, inﬂammation
nd some malignant diseases.7–9 In the last several years,
ccelerating evidence have indicated that AMPK plays critical
oles in the regulation of innate immunity and inﬂammatory
esponses. Galic et al. reported that target deletion of AMPK 1
n mice enhanced adipose tissue macrophage inﬂammation
nd liver insulin resistance.10 While some other researchers
emonstrated that AMPK-1 is essential in mediating TLR4
r TNF- triggered inﬂammatory signals as an activating
inase of TAK1.11,12 AMPK-1 is encoded by PRKAA1 gene
hich is located on chromosome 5p12.1 and constitutes a
9 kb region. Studies have indicated that nucleotide polymor-
hisms in PRKAA1 gene was signiﬁcant associated with the
isk of gastric, colon and rectal cancer.13–16 However, the role of
RKAA1 gene in the immune-response to infectious organisms
emains unknown.
Hepatitis B is one of the most common infectious dis-
ases caused by the hepatitis B virus (HBV) which attacks the
iver. Chronic hepatitis B virus infection (CHB) may lead to
iver ﬁbrosis and cirrhosis, and dramatically increase the inci-
ence of hepatocellular carcinoma (HCC). The susceptibility
nd progression of this disease are known to be inﬂuenced
y viral load, virus genotype, environmental factors, host
mmune responses and host genetic factors.17,18 Considering
he importance of PRKAA1 in the inﬂammatory signaling cas-
ade, we  conducted this case–control study to investigate the
ssociation between PRKAA1 and the susceptibility of chronic
BV infection in Chinese Han population.
aterials  and  methods
tudy  subjects
n this study, we  recruited 276 patients (145 men  and 131
omen; average age, 51.6 years) with chronic HBV infection
nd 303 healthy controls (166 men  and 137 women; aver-
ge age, 54.2 years) from Shaanxi Province People’s Hospital
etween Jan 2012 and Dec 2014. All the subjects were unre-
ated individuals of Chinese Han Population. The patients
ere diagnosed based on serological positivity for HBsAg,
BeAg or anti-HBe and anti-HBc for at least 6 months, and
ersistent abnormality of ALT (alanine aminotransferase) and
ST (aspartate aminotransferase). All the patients were in the6;2 0(6):564–568 565
active hepatitis stage without evidence of liver cirrhosis and
HCC. Patients with other diseases were excluded from this
study. Healthy controls were randomly selected from healthy
persons under routine health screening at the same hospital
during the same time period. They were conﬁrmed to be nega-
tive for HBsAg and HBeAg, without clinical evidence of hepatic
disease, cancer and other disease. The main characteristics of
the subjects are listed in the supplementary Table S1. Writ-
ten informed consent was obtained from each participant of
study. The study protocol conformed to the 1975 Declaration of
Helsinki and was approved by the Research Ethics Committee
of Shaanxi Province People’s Hospital.
Genotyping  of  PRKAA1  gene  polymorphisms
Genomic DNA was isolated from EDTA peripheral blood
using the DNA Extraction Kit (Tiangen Biotech Co., Ltd.,
Beijing, China) following the manufacturer’s instruc-
tions. All DNA samples were ampliﬁed for rs13361707,
rs1002424 and rs3792822 by PCR (polymerase chain reac-
tion) using TaKaRa PCR Ampliﬁcation Kit (Takara Bio Inc.).
The primers were designed using primer 5.0 software
(Molecular Biology Insights) according to the sequence
from NCBI. The primers for rs13361707 primers were:
Forward: 5′-ACGTGTTAAGGAAATAGC-3′, and Reverse: 5′-
AACTGTGTGTATAGTGCAGG-3′. The primers for rs1002424
were: Forward: 5′-AGTTTGGAAGTTATCAGATC-3′, and
Reverse: 5′-ACAGGTGTGAGCCACAGCAC-3′. The primers
for rs3792822 were: Forward: 5′-ACTAGCATCAAAATGTCAGC-
3′, and Reverse: 5′-GACTAGCAAGGCCTAGATCT-3′. The PCR
products were then sequenced and analyzed by ABI 3700 DNA
automated sequencer (Applied Biosystems) according to the
standard protocol.
Statistical  analysis
Data management and statistical analyses were conducted
by STATA software 11.0 version for Windows (StataCorp
LP, College Station, TX, USA). Hardy–Weinberg equilibrium
was tested using the 2 test. Between-group variables were
compared by unpaired Student’s t-test or Mann–Whitney U
test where appropriate, and genotype/allele frequencies were
compared by 2 test. The linkage disequilibrium and haplo-
type construction were performed from the observed geno-
types using SHEsis method (http://www.nhgg.org/analysis),
and odds ratios (OR) with 95% conﬁdence interval (CI) were
calculated. A two-tailed p < 0.05 was accepted as statistically
signiﬁcant.
Results
Single-point  association  analysis
There were no deviations from Hardy–Weinberg equilibrium
for all studied polymorphisms in cases and controls (p > 0.05).
Totally, three SNPs of PRKAA1gene were tested. Rs1002424
polymorphism showed difference in the allele frequen-
cies (p = 0.039411, OR95%CI = 0.783479 [0.621067–0.988362]) but
no differences in the genotype frequencies (p = 0.104758);
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Table 1 – Distribution of genotype and allele frequencies of three SNPs in the PRKAA1 in HBV patients and healthy
controls.
SNP HBV patients Healthy controls OR 95%CI p Value
(n = 276) (n = 303)
rs13361707
Allele(freq) 1.284303 1.017958–1.620335 0.034749
C 269 (0.491) 259 (0.429)
T 279 (0.509) 345 (0.571)
Genotype(freq) 0.098027
CC 71 (0.259) 57 (0.189)
CT 127 (0.464) 145 (0.480)
TT 76 (0.277) 100 (0.331)
HWE 0.228904 0.729947
rs1002424
Allele(freq) 0.783479 0.621067–0.988362 0.039411
C 278(0.507) 343 (0.568)
T 270(0.493) 261 (0.432)
Genotype(freq) 0.104758
CC 76 (0.277) 99 (0.328)
CT 126 (0.460) 145 (0.480)
TT 72 (0.263) 58 (0.192)
HWE 0.184879 0.706059
rs3792822
Allele(freq) 0.741519 0.566439–0.970716 0.029286
A 121 (0.221) 167 (0.276)
G 427 (0.779) 437 (0.724)
Genotype(freq) 0.034560
AA 14 (0.051) 17 (0.056)
AG 93 (0.339) 133 (0.440)
GG 167 (0.609) 152 (0.503)
HWE 0.821795 0.079962Bold numbers represent P-values (P<0.05).
Rs13361707 polymorphism showed signiﬁcance in allele anal-
ysis (p = 0.034749, OR95%CI = 1.284303 [1.017958–1.620335]),
but not in genotype analysis (p = 0.098027); rs3792822 poly-
morphism was demonstrated to have signiﬁcant differ-
ences in both genotype and allele frequencies between
cases and controls (allele: p = 0.029286, OR95%CI = 0.741519
[0.566439–0.970716]; genotype: p = 0.034560) (Table 1).
Haplotype  analysis
The standardized measure of linkage disequilibrium (LD),
denoted as ‘D′’ was estimated at all possible pairs of SNP loci.
LD for each pair of SNPs in cases and controls is presented in
Table 2. The D′-value or r2-value showed strong linkage pat-
terns were observed between rs13361707 and rs1002424 in all
samples (D′ = 0.99), as well as among rs1002424 and rs3792822
Table 2 – Estimation of linkage disequilibrium between
the 3 SNPs.
rs13361707 rs1002424 rs3792822
rs13361707 – 0.996 1.000
rs1002424 0.983 – 1.000
rs3792822 0.282 0.285 –
SNP, single nucleotide polymorphism.
For each pair of SNPs, D′ values are shown above and r2 values below
the diagonal, D’ or r2 > 0.9 are shown in boldface.(D′ = 0.99), and between rs13361707 and rs3792822 (D′ = 0.99)
(Fig. 1).
To facilitate identiﬁcation of combinational effects of these
three polymorphisms on the risk of chronic HBV infection, we
employed haplotype analysis to study the frequency of the
combination of multiple genetic variants. The results showed
that CTG and TCA in the rs13361707–rs1002424–rs3792822
block were signiﬁcantly associated with the development
of chronic HBV infection (CTG: p = 0.036854, OR95%CI = 1.281
[1.015–1.617]; p = 0.030841, OR95%CI = 0.743 [0.568–0.973])
(Table 3).
Discussion
Chronic hepatitis B virus infection (CHB) is one of the
most common infectious disease which leads to a huge
economic problem on health care systems worldwide.
According to the data from WHO,  about 240 million peo-
ple are chronically infected with hepatitis B and more
than 780,000 people die from hepatitis B related dis-
eases including cirrhosis and liver cancer each year
(http://www.who.int/mediacentre/factsheets/fs204/en/).
Thus it is important to clarify the mechanism of chronic HBV
infection. Recent studies have shown that chronic hepatitis
B virus infection is resulted from the interplay between the
virus, host immune system and environmental factors.19,20
Among of them, host genetic backgrounds may be critical for
the susceptibility and various outcomes of this disease.21,22
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Table 3 – Haplotype analysis: rs13361707, rs1002424, rs3792822.
Case (freq) Control (freq) Pearson’s p 2 Odds ratio [95%CI]
C T A 0.01 (0.000) 0.01 (0.000) – – –
C T G* 267.99 (0.489) 258.99 (0.429) 0.036854 4.358 1.281 [1.015–1.617]
T C A* 120.99 (0.221) 166.98 (0.276) 0.030841 4.663 0.743 [0.568–0.973]
T C G* 156.00 (0.285) 176.02 (0.291) 0.818643 0.053 0.971 [0.752–1.253]
T T A 0.00 (0.000) 0.01 (0.000) – – –
T T G 2.00 (0.004) 1.99 (0.003) – – –
C C G 1.00 (0.002) 0.00 (0.000) – – –
(All those frequency <0.03 will be ignored in analysis.)
Global 2 is 5.885321 while df = 2.
Pearson’s p value is 0.052725.
Bold numbers represent P-values (P<0.05).
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Fig. 1 – LD patterns of SNPs rs13361707, rs1002424 and
rs3792822. The linkage patterns between the 3 studied
polymorphisms in all samples. The numbers in diamond
represent the 100× D′ in the form of standard color scheme.
The upper bar denotes the relative distance among the
studied polymorphisms.
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r number of genes have been identiﬁed to be associated
ith chronic hepatitis B virus infection by genome-wide
ssociation studies and case–control studies in the last
everal years.23–25 More  knowledge on the understanding
f candidate genetic factors may provide more  clues to the
revention and therapy of this disease.
It has been well documented that AMPK is an important
egulator of energy-sensing and signaling cascade in mam-
alian cells.26 As a heterotrimeric complex serine/threonine
rotein kinase, AMPK can regulate a variety of other physi-
logical functions such as the regulation of cell proliferation
nd polarity, tumorigenesis, autophagy and innate immune
esponses.27 However, the signaling properties are diversedepending on the different combination of subunit iso-
forms of AMPK in various cells.28 Some studies indicated
that AMPK may restrict HBV replication through promotion
of autophagic degradation, but the underlying mechanism
remains to be elucidated.29 The 1 catalytic subunit of
AMPK encoded by PRKAA1 gene, is mainly expressed in
lymphocytes and macrophages. AMPK1  has been demon-
strated to play a pivotal role in inducing pro-inﬂammatory
signals through the activation of TAK1 and NF-B,30 but
its role in chronic HBV infection remains unclear. So, this
current study might be the ﬁrst attempt to assess the
association between polymorphisms in PRAA1 gene and
chronic HBV infection. The results showed that all the three
polymorphisms we tested were associated with the sus-
ceptibility of chronic HBV infection (rs3792822 in both the
allele- and genotype-analyses; rs13361707 and rs1002424 in
allele-analyses). Based on the value of D′, the following
haplotype-analyses were done and the results showed that,
in the block of ‘rs13361707–rs1002424–rs3792822′, C T G and
T C A were associated with chronic hepatitis B virus infec-
tion, suggesting that AMPK1  may play some critical roles
in the regulation of the initial defense against hepatitis
B virus.
Taken together, the results of our study indicated that
PRKAA1 gene is associated with the development of chronic
HBV infection in Chinse Han Population. Although replica-
tions with larger sample size and functional studies to further
clarify the role that PRKAA1/AMPK1 are needed, the current
study gave some clues which is useful in better understand-
ing the intrinsic relationship between PRKAA1/AMPK1 and
the pathogenesis of chronic HBV infection.
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Appendix  A.  Supplementary  data
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.bjid.2016.08.003.
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